EVIO, Inc. Enters into Letter of Intent to Acquire Leading Edge Pharms, Inc.


EVIO Inc. (OTC: EVIO) is pleased to announce that is has entered into a Letter of Intent to acquire Leading Edge Pharms, Inc. (LEP) of Henderson, Nevada. LEP is a biotechnology company focused on the research, development, and commercialization of novel cannabinoid therapies and innovative drug delivery systems that provide safe and effective topical solutions for pain management. LEP offers proprietary formulations and a non-systemic delivery system to enhance the permeation and relief process for topically delivered medication to damaged skin, muscle, joint, and nerve tissue. LEP has formulated a line of products including CANNAVERA, a family of topical pain relief products currently pending for over-the-counter (OTC) registration with the FDA. The company has several other products and trademarked brands in late stages of development, including cosmetics, feminine care, pet health and wellness, and dental and oral care products. All products are manufactured in an FDA-registered facility and follow Current Good Manufacturing Practice (CGMP) guidelines. All ingredients are certified natural and safe. Terms of the acquisition include EVIO performing detailed due diligence, including technical review and testing of the company’s products and methods. Pending regulatory review and shareholder approval, EVIO will authorize additional shares to support the acquisition. EVIO will also add at least two board members and executive positions from LEP, and EVIO will release its audited financials. Lori Glauser, interim CEO, says, “While EVIO continues to operate in the testing space, we have been on the lookout for complimentary businesses that align with our mission and also strengthen our portfolio.  Leading Edge Pharms offers an established product line with proven efficacy that offers higher margins and entrance into the consumer marketplace. I am also pleased to partner with a strong team of experienced executives who will help lift EVIO to the next level.” Strategic Deal Highlights: The LEP acquisition…

Excerpt only …
Source : EVIO, Inc. Enters into Letter of Intent to Acquire Leading Edge Pharms, Inc.

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.